[1]李亚岚 王彦.肌少症对老年2型糖尿病患者的影响及干预措施[J].国际内分泌代谢杂志,2018,38(05):317-320.[doi:10.3760/cma.j.issn.1673-4157.2018.05.008]
 Li Yalan,Wang Yan.Impact of sarcopenia on elderly patients with type 2 diabetes mellitus and interventions[J].International Journal of Endocrinology and Metabolism,2018,38(05):317-320.[doi:10.3760/cma.j.issn.1673-4157.2018.05.008]
点击复制

肌少症对老年2型糖尿病患者的影响及干预措施()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
38
期数:
2018年05期
页码:
317-320
栏目:
临床研究
出版日期:
2018-09-20

文章信息/Info

Title:
Impact of sarcopenia on elderly patients with type 2 diabetes mellitus and interventions
作者:
李亚岚 王彦
作者单位:030000 太原,山西医科大学第一医院内分泌科
Author(s):
Li Yalan Wang Yan
Department of Endocrinology, The First Hospital, Shanxi Medical University, Taiyuan 030000, China
关键词:
肌少症 2型糖尿病 骨骼肌
Keywords:
Sarcopenia Type 2 diabetes mellitus Skeletal muscle
DOI:
10.3760/cma.j.issn.1673-4157.2018.05.008
摘要:
随着增龄和糖尿病病程的进展,老年2型糖尿病患者的骨骼肌数量、质量及功能逐渐下降,可导致肌少症的发生; 而发生的肌少症反之会加重糖尿病患者的病情,成为老年2型糖尿病患者不可忽视的新型威胁。因此,在老年2型糖尿病患者中主动防治肌少症至关重要。充足的营养、适量的运动、良好的血糖控制及合理使用降糖药物等联合干预可能会有助于肌少症的防治。
Abstract:
The mass, strength and function of skeletal muscle of elderly patients with type 2 diabetes mellitus(T2DM)may gradually decline, along with the increase of age and the progression of diabetes, thus leading to the occurrence of sarcopenia which can also aggravates the condition of T2DM. Therefore, sarcopenia is a new emerging threat of diabetic patients that can not be ignored. In this case, active prevention and treatment of sarcopenia in elderly patients with T2DM is crucial. A multimodal intervention which includes adequate nutrition, moderate exercise, good glycaemic control and the use of appropriate hypoglycemic medications may contribute to the prevention and treatment of sarcopenia.

参考文献/References:


[1] Kim KS, Park KS,Kim MJ,et al.Type 2 diabetes is associated with low muscle mass in older adults[J].Geriatr Gerontol Int,2014,14(Suppl 1):115-121.DOI:10.1111/ggi.12189.
[2] Kirkman MS,Briscoe VJ,Clark N,et al.Diabetes in older adults[J].Diabetes Care,2012,35(12):2650-2664.DOI:10.2337/dc12-1801.
[3] Wong E,Backholer K,Gearon E,et al.Diabetes and risk of physical disability in adults: a systematic review and meta-analysis[J].Lancet Diabetes Endocrinol,2013,1(2):106-114.DOI:10.1016/S2213-8587(13)70046-9.
[4] Tanaka K,Kanazawa I,Sugimoto T.Reduction in endogenous insulin secretion is a risk factor of sarcopenia in men with type 2 diabetes mellitus[J].Calcif Tissue Int,2015,97(4):385-390.DOI:10.1007/s00223-015-9990-8.
[5] Cruz-Jentoft AJ,Baeyens JP,Bauer JM,et al.Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People[J].Age Ageing,2010,39(4):412-423.DOI:10.1093/ageing/afq034.
[6] Bonewald LF,Kiel DP,Clemens TL,et al.Forum on bone and skeletal muscle interactions: summary of the proceedings of an ASBMR workshop[J].J Bone Miner Res,2013,28(9):1857-1865.DOI:10.1002/jbmr.1980.
[7] Calvani R,Joseph AM,Adhihetty PJ,et al.Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy[J].Biol Chem,2013,394(3):393-414.DOI:10.1515/hsz-2012-0247.
[8] Gonzalez-Freire M,de Cabo R,Studenski SA,et al.The neuromuscular junction: aging at the crossroad between nerves and muscle[J].Front Aging Neurosci,2014,6:208.DOI:10.3389/fnagi.2014.00208.
[9] Beaudart C,Rizzoli R,Bruyère O,et al.Sarcopenia: burden and challenges for public health[J].Arch Public Health,2014,72(1):45.DOI:10.1186/2049-3258-72-45.
[10] Han P,Yu H,Ma Y,et al.The increased risk of sarcopenia in patients with cardiovascular risk factors in Suburb-Dwelling older Chinese using the AWGS definition[J].Sci Rep,2017,7(1):9592.DOI:10.1038/s41598-017-08488-8.
[11] Wang T,Feng X,Zhou J,et al.Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly[J].Sci Rep,2016,6:38937.DOI:10.1038/srep38937.
[12] Kalyani RR,Metter EJ,Egan J,et al.Hyperglycemia predicts persistently lower muscle strength with aging[J].Diabetes Care,2015,38(1):82-90.DOI:10.2337/dc14-1166.
[13] Fukuda T,Bouchi R,Takeuchi T,et al.Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes:a cross-sectional study[J].BMJ Open Diabetes Res Care,2017,5(1):e000404.DOI:10.1136/bmjdrc-2017-000404.
[14] Rai M,Demontis F.Systemic nutrient and stress signaling via myokines and myometabolites[J].Annu Rev Physiol,2016,78:85-107.DOI:10.1146/annurev-physiol-021115-105305.
[15] Cleasby ME,Jamieson PM,Atherton PJ.Insulin resistance and sarcopenia: mechanistic links between common co-morbidities[J].J Endocrinol,2016,229(2):R67-R81.DOI:10.1530/JOE-15-0533.
[16] Lu CW,Yang KC,Chang HH,et al.Sarcopenic obesity is closely associated with metabolic syndrome[J].Obes Res Clin Pract,2013,7(4):e301-e307.DOI:10.1016/j.orcp.2012.02.003.
[17] Cheng Q,Hu J,Yang P,et al.Sarcopenia is independently associated with diabetic foot disease[J].Sci Rep,2017,7(1):8372.DOI:10.1038/s41598-017-08972-1.
[18] Bouchi R,Fukuda T,Takeuchi T,et al.Sarcopenia is associated with incident albuminuria in patients with type 2 diabetes: a retrospective observational study[J].J Diabetes Investig,2017,8(6):783-787.DOI:10.1111/jdi.12636.
[19] Tanaka KI,Kanazawa I,Sugimoto T.Reduced muscle mass and accumulation of visceral fat are independently associated with increased arterial stiffness in postmenopausal women with type 2 diabetes mellitus[J].Diabetes Res Clin Pract,2016,122:141-147.DOI:10.1016/j.diabres.2016.10.014.
[20] Olsson K,Saini A,Strömberg A,et al.Evidence for vitamin D receptor expression and direct effects of 1α,25(OH)2D3 in human skeletal muscle precursor cells[J].Endocrinology,2016,157(1):98-111.DOI:10.1210/en.2015-1685.
[21] Wee AK.Serum folate predicts muscle strength: a pilot cross-sectional study of the association between serum vitamin levels and muscle strength and gait measures in patients >65 years old with diabetes mellitus in a primary care setting[J].Nutr J,2016,15(1):89.DOI:10.1186/s12937-016-0208-3.
[22] Ribeiro MBT,Guzzoni V,Hord JM,et al.Resistance training regulates gene expression of molecules associated with intramyocellular lipids, glucose signaling and fiber size in old rats[J].Sci Rep,2017,7(1):8593.DOI:10.1038/s41598-017-09343-6.
[23] Miller T,Mull S,Aragon AA,et al.Resistance training combined with diet decreases body fat while preserving lean mass independent of resting metabolic rate:a randomized trial[J].Int J Sport Nutr Exerc Metab,2018,28(1):46-54.DOI:10.1123/ijsnem.2017-0221.
[24] Aghili R,Malek M,Valojerdi AE,et al.Body composition in adults with newly diagnosed type 2 diabetes: effects of metformin[J].J Diabetes Metab Disord,2014,13(1):88.DOI:10.1186/s40200-014-0088-z.
[25] Mele A,Calzolaro S,Cannone G,et al.Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle[J].Pharmacol Res Perspect,2014,2(1):e00028.DOI:10.1002/prp2.28.

相似文献/References:

[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
 Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(05):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
 Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(05):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
 Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
 Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(05):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
 Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(05):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性 血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
 Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(05):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白 与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
 Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(05):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平 及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
 Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(05):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
 Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(05):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病 患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
 Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
[11]李亚岚 高月琴 王彦.老年2型糖尿病患者肌肉量减少与白蛋白尿的相关性研究[J].国际内分泌代谢杂志,2020,40(02):77.[doi:10.3760/cma.j.issn.1673-4157.2020.02.002]
 Li Yalan,Gao Yueqin,Wang Yan.Relationship between low muscle mass and albuminuria in elderly patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2020,40(05):77.[doi:10.3760/cma.j.issn.1673-4157.2020.02.002]

备注/Memo

备注/Memo:
作者单位:030000 太原,山西医科大学第一医院内分泌科
通信作者:王彦,Email: wyroad@126.com
更新日期/Last Update: 2018-09-30